Arizona State Retirement System - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 188 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Arizona State Retirement System ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$70,658
-32.8%
16,356
+2.5%
0.00%0.0%
Q2 2023$105,111
-5.6%
15,950
-2.7%
0.00%0.0%
Q1 2023$111,336
-5.6%
16,397
+2.7%
0.00%0.0%
Q4 2022$117,944
-22.4%
15,960
+4.0%
0.00%
-50.0%
Q3 2022$152,000
-7.9%
15,351
+1.3%
0.00%0.0%
Q2 2022$165,000
-2.9%
15,151
+0.6%
0.00%
+100.0%
Q1 2022$170,000
-27.7%
15,060
+0.6%
0.00%
-50.0%
Q4 2021$235,000
-9.3%
14,975
-1.1%
0.00%0.0%
Q3 2021$259,000
-19.3%
15,135
+1.4%
0.00%
-33.3%
Q2 2021$321,000
+34.3%
14,919
-6.3%
0.00%
+50.0%
Q1 2021$239,000
+14.9%
15,921
+0.5%
0.00%0.0%
Q4 2020$208,000
+30.8%
15,838
-3.8%
0.00%0.0%
Q3 2020$159,000
+14.4%
16,460
+35.9%
0.00%0.0%
Q2 2020$139,000
+18.8%
12,109
+7.4%
0.00%0.0%
Q1 2020$117,000
-80.0%
11,270
-68.3%
0.00%
-71.4%
Q4 2019$584,000
-29.7%
35,567
-43.2%
0.01%
-30.0%
Q3 2019$831,000
-28.2%
62,569
-23.8%
0.01%
-23.1%
Q2 2019$1,158,000
-22.5%
82,158
+1.2%
0.01%
-27.8%
Q1 2019$1,494,000
-29.2%
81,209
+0.5%
0.02%
-33.3%
Q4 2018$2,111,000
-29.3%
80,772
-37.9%
0.03%
-3.6%
Q3 2018$2,984,000130,0000.03%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders